Back

Meningococcal Septic Shock

Meningococcal septic shock is fulminant bloodstream infection with Neisseria meningitidis causing circulatory collapse, purpura, disseminated intravascular coagulation and multi-organ failure, with or without meningitis. Death can occur within hours.

Epidemiology. Peaks occur in infants, adolescents and young adults. Serogroups B, C, W, Y and A cause most disease, with serogroup A and W epidemics in the African meningitis belt. Case fatality for septicaemia is about 10 to 20% with treatment and is higher in shock.

Risk factors. Complement deficiency (terminal components, properdin), asplenia, HIV, eculizumab or ravulizumab treatment, close contact with a case, crowded settings (students, military recruits), smoking and recent viral infection.

Pathophysiology. Endotoxin (lipo oligosaccharide) and high bacterial load trigger severe inflammation, endothelial injury, capillary leak and DIC with microvascular thrombosis. Myocardial depression and adrenal injury are common.

Related

Clinical toolsCalculators

Latest content

Atlas’ Videos

On the evidence

Doses are traceable.

Management sections cite the guideline they came from. Atlas supports clinical judgement rather than replacing it; verify against current national guidance and the patient in front of you.

Learn it.
Know it.
Own it.